We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

102 hedge funds and large institutions have $405M invested in VanEck Pharmaceutical ETF in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

392% more call options, than puts

Call options by funds: $551K | Put options by funds: $112K

44% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 25

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

3% more capital invested

Capital invested by funds: $392M → $405M (+$12.6M)

0% more funds holding

Funds holding: 102 → 102 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

12.44% less ownership

Funds ownership: 107.35% → 94.91% (-12%)

Holders
102
Holders Change
–
Holders Change %
0%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
36
Reduced
25
Closed
13
Calls
$551K
Puts
$112K
Net Calls
+$439K
Net Calls Change
-$87K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$42.9M
2
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
+$12.3M
3
JP Morgan Chase
JP Morgan Chase
New York
+$12.1M
4
IAA
Independent Advisor Alliance
North Carolina
+$3.96M
5
Morgan Stanley
Morgan Stanley
New York
+$2.34M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$27.9M
2
PF
Phoenix Financial
Israel
-$22.8M
3
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$12M
4
HighTower Advisors
HighTower Advisors
Illinois
-$3.71M
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$2.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
Comerica Bank
76
Comerica Bank
Texas
$58.9K +$59.5K +738 New
BCV
77
Banque Cantonale Vaudoise
Switzerland
$57K – – –
MA
78
Montag & Associates
Georgia
$52.7K -$58.1K -720 -52%
Wells Fargo
79
Wells Fargo
California
$50K -$420K -5,214 -89%
TWC
80
TD Waterhouse Canada
Ontario, Canada
$41.3K -$1.56M -19,366 -97%
CIAS
81
Capital Investment Advisory Services
North Carolina
$37.9K – – –
WTG
82
West Tower Group
Virginia
$34K +$34.4K +426 New
FDCDDQ
83
Federation des caisses Desjardins du Quebec
Quebec, Canada
$31.9K – – –
HPC
84
HM Payson & Co
Maine
$19.9K +$81 +1 +0.4%
Fidelity Investments
85
Fidelity Investments
Massachusetts
$17.3K – – –
IA
86
IFP Advisors
Florida
$17.2K – – –
Citigroup
87
Citigroup
New York
$16K -$651K -8,067 -98%
AF
88
Advisornet Financial
Minnesota
$16K – – –
RAM
89
Riggs Asset Management
Pennsylvania
$11.1K -$341K -4,229 -97%
HCM
90
Highlander Capital Management
New Jersey
$11K – – –
YDMI
91
Y.D. More Investments
Israel
$9.58K – – –
BBPWM
92
Blue Bell Private Wealth Management
Pennsylvania
$6.23K – – –
MIM
93
Macroview Investment Management
Maryland
$5.03K – – –
VanEck Associates
94
VanEck Associates
New York
$5K – – –
AIM
95
Anchor Investment Management
South Carolina
$4.63K – – –
CAS
96
Coppell Advisory Solutions
Texas
$4.05K – – –
DJSG
97
D.J. St. Germain
Massachusetts
$3.99K +$4.03K +50 New
SWA
98
SOA Wealth Advisors
New York
$2.7K – – –
GRP
99
Global Retirement Partners
California
$1.2K -$4.84K -60 -80%
FWM
100
Focused Wealth Management
New York
$1.12K – – –
1 2 3
4
5

PPH Hedge Fund Activity: Q3 2023 in Review

102 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q3 2023, worth a combined $405M — up 3.2% from $392M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new PPH positions and 13 closed out — a net gain of 1 holder — while 36 added to existing stakes and 25 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $42.9M. The largest seller was Bank of America, cutting an estimated $27.9M.

  • 102 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $405M of VanEck Pharmaceutical ETF stock for Q3 2023, up 3.2% quarter-over-quarter.
  • 14 funds opened new VanEck Pharmaceutical ETF positions in Q3 2023 and 13 closed out, a net change of +1 holder.
  • The largest VanEck Pharmaceutical ETF buyer in Q3 2023 was Goldman Sachs, an estimated $42.9M added.
  • The largest VanEck Pharmaceutical ETF seller in Q3 2023 was Bank of America, an estimated $27.9M sold.

Based on aggregated 13F filings for Q3 2023.